<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Zavedos; Idarubicin" /><meta name="IX" content="Zavedos; Idarubicin" /><title>Zavedos®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="4718.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="4718.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=4718.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2075.htm">8 Malignant disease and immunosuppression</a> &gt; <a href="4676.htm">8.1 Cytotoxic drugs</a> &gt; <a href="4704.htm">8.1.2 Anthracyclines and other cytotoxic antibiotics</a> &gt; <a href="4717.htm">IDARUBICIN HYDROCHLORIDE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="4714.htm" title="Previous: EPIRUBICIN HYDROCHLORIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="4719.htm" title="Next: MITOMYCIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a303037.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Idarubicin Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Antineoplastic Agents 10:00</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/19335-w.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Idarubicin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: I &gt; Interactions of Idarubicin</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="4704.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">8.1.2 Anthracyclines and other cytotoxic antibiotics</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs</p></div></li><li><a href="4717.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">IDARUBICIN HYDROCHLORIDE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.1 Cytotoxic drugs &gt; 8.1.2 Anthracyclines and other cytotoxic antibiotics</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0874.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Idarubicin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; I</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a591004.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Idarubicin Hydrochloride</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; I</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/12058-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Idarubicin Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antineoplastics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04886.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Idarubicin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; I &gt; ID</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E4E3E0R0D1585.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Idarubicin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_4717">IDARUBICIN HYDROCHLORIDE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i1164.htm" title="Go to appendix 1">Idarubicin</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">acute leukaemias (see <a title="target-block: IDARUBICIN NOTES " href="4704.htm#_1199883355254">notes above</a>); advanced breast cancer after
failure of first-line chemotherapy (not including anthracyclines)</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title=" Cytotoxic drugs" href="4676.htm#_4676">section 8.1</a> and <a title="target-block: IDARUBICIN NOTES " href="4704.htm#_1199883355254">notes above</a>; caution in handling—irritant
to tissues; <b>interactions</b>: Appendix
1 (idarubicin) </p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">severe myocardial insufficiency; recent myocardial infarction; severe arrhythmias; previous
treatment with maximum cumulative dose of idarubicin or other anthracycline</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">reduce dose according to serum-bilirubin concentration;
avoid in severe impairment</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">reduce dose; avoid in severe impairment</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">avoid (teratogenic and toxic in <i>animal</i> studies); see also <a title="target-block: Cytotoxic drugs: Reproductive function" href="100100.htm#_100100.2">Pregnancy and Reproductive
Function</a></p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">discontinue breast-feeding</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see <a title="topic: Side-effects of cytotoxic drugs" href="100100.htm#_100100">section 8.1</a> and <a title="target-block: IDARUBICIN NOTES " href="4704.htm#_1199883355254">notes above</a></p></div><div class="cAF"><h2>Dose</h2> <p class="cR"><span class="cU">By mouth</span>, acute non-lymphocytic leukaemia,
monotherapy, 30 mg/m<sup>2</sup> daily for 3 days <i>or</i> in combination therapy, 15–30 mg/m<sup>2</sup> daily for 3 days</p><p class="cS">Advanced breast cancer, monotherapy, 45 mg/m<sup>2</sup> as
a single dose <i>or</i> 15 mg/m<sup>2</sup> daily for 3
consecutive days; repeat every 3–4 weeks</p><div class="cAR"><h3>Note</h3> <p class="cAX">Max. cumulative dose <span class="cU">by mouth</span> (for all indications) 400 mg/m<sup>2</sup></p></div><p class="cR"><span class="cU">By intravenous administration</span>, consult product
literature</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_4718" style="margin: 0 0 0 20px;"><h1 class="title">Zavedos®<span> (<a href="appendix-112803-P.htm#m163">Pharmacia</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Capsules</span>, <span>idarubicin hydrochloride</span>, 5 mg (red), net price 1-cap pack = £41.47; 10 mg (red/white), 1-cap
pack = £69.12. 
    Label:
    25</div><div class="cAY"><span class="cAB">Injection</span>, powder for reconstitution, <span>idarubicin hydrochloride</span>, net price 5-mg vial = £87.36;
10-mg vial = £174.72</div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="4714.htm">Previous: EPIRUBICIN HYDROCHLORIDE</a> | <a class="top" href="4718.htm#">Top</a> | <a accesskey="]" href="4719.htm">Next: MITOMYCIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>